Article info

Download PDFPDF

Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life

Authors

  1. Correspondence to Professor Gian Paolo Fadini; gianpaolofadini{at}hotmail.com
View Full Text

Citation

Longato E, Di Camillo B, Sparacino G, et al
Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life

Publication history

  • Received April 8, 2020
  • Revised May 12, 2020
  • Accepted May 24, 2020
  • First published June 25, 2020.
Online issue publication 
June 25, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.